-
-
-
-
-
-
-
Vivos Therapeutics reports 70% revenue growth in first quarter
-
-
-
-
-
-
-
Vivos Therapeutics gains Nevada insurance coverage, cuts costs
-
-
-
-
-
-
-
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds
-
-
-
-
-
-
-
Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call
-
-
-
-
-
-
-
New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children
-
-
-
-
-
-
-
Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update
-
-
-
-
-
-
-
Vivos Therapeutics (VVOS) Announces Acquisition of Product Rights and Patents from Advanced Facialdontics, LLC
-
1,165,894 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

